Mithra Provides Supplementary Details on Estelle® US Deal with Mayne
(WorldNews Belgium)

03-10-2019 PRESS RELEASE Mithra Provides Supplementary Details on Estelle® US Deal with Mayne Liege, Belgium, 3 October 2019 - 7 :30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women`s Health today provides supplementary details related to the US deal with Mayne Pharma for Estelle®. Under the terms of the 20-year agreement, Mithra will receive: Minimum of USD 295 million (USD 308.1 million actualized) in license fees, comprised of milestone fees in cash and in equity (+ USD 13.1 million actualized1), plus Fixed supply price per product, and a Variable supply price based on a percentage (high double-digits) of net sales. Mithra would additionally like to clarify the...